Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by 'inadequate bone mineralization' (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder.
LPI (LP Information)' newest research report, the “Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Forecast” looks at past sales and reviews total world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales for 2023 through 2029. With Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.
This Insight Report provides a comprehensive analysis of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) players cover Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol and Japan Tobacco Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market?
What factors are driving Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market opportunities vary by end market size?
How does Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by 'inadequate bone mineralization' (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder.
LPI (LP Information)' newest research report, the “Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Industry Forecast” looks at past sales and reviews total world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales in 2022, providing a comprehensive analysis by region and market sector of projected Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales for 2023 through 2029. With Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) industry.
This Insight Report provides a comprehensive analysis of the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD).
The global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) players cover Akebia, Astellas, Takeda, Vifor, Abbvie, Fresenius, Abbott, Novadiol and Japan Tobacco Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Control Hyperphosphatemia
- Maintain Blood Calcium Levels
- Control PTH Level
- Correct Acidosis
- Other
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Akebia
- Astellas
- Takeda
- Vifor
- Abbvie
- Fresenius
- Abbott
- Novadiol
- Japan Tobacco Company
- Daiichi-Sankyo
- Shield
- Spectrum
- OPKO
- Ardelyx
- Sanofi Genzyme
- Amgen
What is the 10-year outlook for the global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market?
What factors are driving Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) market opportunities vary by end market size?
How does Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country/Region, 2018, 2022 & 2029
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
2.2.1 Control Hyperphosphatemia
2.2.2 Maintain Blood Calcium Levels
2.2.3 Control PTH Level
2.2.4 Correct Acidosis
2.2.5 Other
2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2018-2023)
2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Drug Stores
2.4.5 Other
2.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2018-2023)
2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2018-2023)
3 GLOBAL CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY COMPANY
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Breakdown Data by Company
3.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Company (2018-2023)
3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2018-2023)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Company (2018-2023)
3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2018-2023)
3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2018-2023)
3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company
3.4 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Location Distribution
3.4.2 Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
4.1 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Geographic Region (2018-2023)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country/Region (2018-2023)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.4 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
5 AMERICAS
5.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
5.1.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023)
5.1.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023)
5.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
5.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
6.1.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2018-2023)
6.1.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2018-2023)
6.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
6.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023)
7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023)
7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
8.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023)
8.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
8.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.3 Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.4 Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
11.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer
12 WORLD FORECAST REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region
12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Region (2024-2029)
12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type
12.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Akebia
13.1.1 Akebia Company Information
13.1.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Akebia Main Business Overview
13.1.5 Akebia Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Vifor
13.4.1 Vifor Company Information
13.4.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Vifor Main Business Overview
13.4.5 Vifor Latest Developments
13.5 Abbvie
13.5.1 Abbvie Company Information
13.5.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abbvie Main Business Overview
13.5.5 Abbvie Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Novadiol
13.8.1 Novadiol Company Information
13.8.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novadiol Main Business Overview
13.8.5 Novadiol Latest Developments
13.9 Japan Tobacco Company
13.9.1 Japan Tobacco Company Company Information
13.9.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Japan Tobacco Company Main Business Overview
13.9.5 Japan Tobacco Company Latest Developments
13.10 Daiichi-Sankyo
13.10.1 Daiichi-Sankyo Company Information
13.10.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Daiichi-Sankyo Main Business Overview
13.10.5 Daiichi-Sankyo Latest Developments
13.11 Shield
13.11.1 Shield Company Information
13.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shield Main Business Overview
13.11.5 Shield Latest Developments
13.12 Spectrum
13.12.1 Spectrum Company Information
13.12.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Spectrum Main Business Overview
13.12.5 Spectrum Latest Developments
13.13 OPKO
13.13.1 OPKO Company Information
13.13.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 OPKO Main Business Overview
13.13.5 OPKO Latest Developments
13.14 Ardelyx
13.14.1 Ardelyx Company Information
13.14.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ardelyx Main Business Overview
13.14.5 Ardelyx Latest Developments
13.15 Sanofi Genzyme
13.15.1 Sanofi Genzyme Company Information
13.15.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sanofi Genzyme Main Business Overview
13.15.5 Sanofi Genzyme Latest Developments
13.16 Amgen
13.16.1 Amgen Company Information
13.16.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Amgen Main Business Overview
13.16.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country/Region, 2018, 2022 & 2029
2.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Type
2.2.1 Control Hyperphosphatemia
2.2.2 Maintain Blood Calcium Levels
2.2.3 Control PTH Level
2.2.4 Correct Acidosis
2.2.5 Other
2.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
2.3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
2.3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Type (2018-2023)
2.3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2018-2023)
2.4 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.4.4 Drug Stores
2.4.5 Other
2.5 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
2.5.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Market Share by Application (2018-2023)
2.5.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue and Market Share by Application (2018-2023)
2.5.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2018-2023)
3 GLOBAL CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY COMPANY
3.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Breakdown Data by Company
3.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Company (2018-2023)
3.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2018-2023)
3.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Company (2018-2023)
3.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2018-2023)
3.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2018-2023)
3.3 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company
3.4 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Location Distribution
3.4.2 Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
4.1 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Geographic Region (2018-2023)
4.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size by Country/Region (2018-2023)
4.2.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales by Country/Region (2018-2023)
4.2.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue by Country/Region (2018-2023)
4.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.4 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.5 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
4.6 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth
5 AMERICAS
5.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country
5.1.1 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023)
5.1.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023)
5.2 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
5.3 Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region
6.1.1 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2018-2023)
6.1.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2018-2023)
6.2 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
6.3 APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
7.1.1 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023)
7.1.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023)
7.2 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
7.3 Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) by Country
8.1.1 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023)
8.1.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023)
8.2 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type
8.3 Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.3 Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
10.4 Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors
11.3 Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer
12 WORLD FORECAST REVIEW FOR CHRONIC KIDNEY DISEASE–MINERAL AND BONE DISORDERS (CKD-MBD) BY GEOGRAPHIC REGION
12.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market Size Forecast by Region
12.1.1 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Region (2024-2029)
12.1.2 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Type
12.7 Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Akebia
13.1.1 Akebia Company Information
13.1.2 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.1.3 Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Akebia Main Business Overview
13.1.5 Akebia Latest Developments
13.2 Astellas
13.2.1 Astellas Company Information
13.2.2 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.2.3 Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Astellas Main Business Overview
13.2.5 Astellas Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.3.3 Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Vifor
13.4.1 Vifor Company Information
13.4.2 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.4.3 Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Vifor Main Business Overview
13.4.5 Vifor Latest Developments
13.5 Abbvie
13.5.1 Abbvie Company Information
13.5.2 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.5.3 Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Abbvie Main Business Overview
13.5.5 Abbvie Latest Developments
13.6 Fresenius
13.6.1 Fresenius Company Information
13.6.2 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.6.3 Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Fresenius Main Business Overview
13.6.5 Fresenius Latest Developments
13.7 Abbott
13.7.1 Abbott Company Information
13.7.2 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.7.3 Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Abbott Main Business Overview
13.7.5 Abbott Latest Developments
13.8 Novadiol
13.8.1 Novadiol Company Information
13.8.2 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.8.3 Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Novadiol Main Business Overview
13.8.5 Novadiol Latest Developments
13.9 Japan Tobacco Company
13.9.1 Japan Tobacco Company Company Information
13.9.2 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.9.3 Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Japan Tobacco Company Main Business Overview
13.9.5 Japan Tobacco Company Latest Developments
13.10 Daiichi-Sankyo
13.10.1 Daiichi-Sankyo Company Information
13.10.2 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.10.3 Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Daiichi-Sankyo Main Business Overview
13.10.5 Daiichi-Sankyo Latest Developments
13.11 Shield
13.11.1 Shield Company Information
13.11.2 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.11.3 Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Shield Main Business Overview
13.11.5 Shield Latest Developments
13.12 Spectrum
13.12.1 Spectrum Company Information
13.12.2 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.12.3 Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Spectrum Main Business Overview
13.12.5 Spectrum Latest Developments
13.13 OPKO
13.13.1 OPKO Company Information
13.13.2 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.13.3 OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 OPKO Main Business Overview
13.13.5 OPKO Latest Developments
13.14 Ardelyx
13.14.1 Ardelyx Company Information
13.14.2 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.14.3 Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Ardelyx Main Business Overview
13.14.5 Ardelyx Latest Developments
13.15 Sanofi Genzyme
13.15.1 Sanofi Genzyme Company Information
13.15.2 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.15.3 Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sanofi Genzyme Main Business Overview
13.15.5 Sanofi Genzyme Latest Developments
13.16 Amgen
13.16.1 Amgen Company Information
13.16.2 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
13.16.3 Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Amgen Main Business Overview
13.16.5 Amgen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Control Hyperphosphatemia
Table 4. Major Players of Maintain Blood Calcium Levels
Table 5. Major Players of Control PTH Level
Table 6. Major Players of Correct Acidosis
Table 7. Major Players of Other
Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2018-2023) & ($ million)
Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2018-2023)
Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2018-2023) & (USD/Kg)
Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2018-2023)
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2018-2023)
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2018-2023) & (USD/Kg)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2018-2023) & (MT)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2018-2023)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2018-2023)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company (2018-2023) & (USD/Kg)
Table 23. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution and Sales Area
Table 24. Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
Table 25. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2018-2023) & (MT)
Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Geographic Region (2018-2023)
Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country/Region (2018-2023) & (MT)
Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2018-2023)
Table 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023) & (MT)
Table 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2018-2023)
Table 38. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2018-2023)
Table 40. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 41. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 42. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2018-2023) & (MT)
Table 43. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2018-2023)
Table 44. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2018-2023)
Table 46. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 47. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023) & (MT)
Table 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2018-2023)
Table 50. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2018-2023)
Table 52. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 53. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 54. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023) & (MT)
Table 55. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 59. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 60. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 61. Key Market Challenges & Risks of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 62. Key Industry Trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 63. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 66. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer List
Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2024-2029) & (MT)
Table 68. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2024-2029) & (MT)
Table 70. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2024-2029) & (MT)
Table 72. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2024-2029) & (MT)
Table 74. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2024-2029) & (MT)
Table 76. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2024-2029) & (MT)
Table 78. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2024-2029) & (MT)
Table 80. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Akebia Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 82. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 83. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 84. Akebia Main Business
Table 85. Akebia Latest Developments
Table 86. Astellas Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 87. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 88. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 89. Astellas Main Business
Table 90. Astellas Latest Developments
Table 91. Takeda Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 92. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 93. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 94. Takeda Main Business
Table 95. Takeda Latest Developments
Table 96. Vifor Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 97. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 98. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 99. Vifor Main Business
Table 100. Vifor Latest Developments
Table 101. Abbvie Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 102. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 103. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 104. Abbvie Main Business
Table 105. Abbvie Latest Developments
Table 106. Fresenius Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 107. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 108. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 109. Fresenius Main Business
Table 110. Fresenius Latest Developments
Table 111. Abbott Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 112. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 113. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 114. Abbott Main Business
Table 115. Abbott Latest Developments
Table 116. Novadiol Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 117. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 118. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 119. Novadiol Main Business
Table 120. Novadiol Latest Developments
Table 121. Japan Tobacco Company Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 122. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 123. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 124. Japan Tobacco Company Main Business
Table 125. Japan Tobacco Company Latest Developments
Table 126. Daiichi-Sankyo Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 127. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 128. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 129. Daiichi-Sankyo Main Business
Table 130. Daiichi-Sankyo Latest Developments
Table 131. Shield Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 132. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 133. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 134. Shield Main Business
Table 135. Shield Latest Developments
Table 136. Spectrum Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 137. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 138. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 139. Spectrum Main Business
Table 140. Spectrum Latest Developments
Table 141. OPKO Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 142. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 143. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 144. OPKO Main Business
Table 145. OPKO Latest Developments
Table 146. Ardelyx Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 147. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 148. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 149. Ardelyx Main Business
Table 150. Ardelyx Latest Developments
Table 151. Sanofi Genzyme Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 152. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 153. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 154. Sanofi Genzyme Main Business
Table 155. Sanofi Genzyme Latest Developments
Table 156. Amgen Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 157. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 158. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 159. Amgen Main Business
Table 160. Amgen Latest Developments
Table 1. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Control Hyperphosphatemia
Table 4. Major Players of Maintain Blood Calcium Levels
Table 5. Major Players of Control PTH Level
Table 6. Major Players of Correct Acidosis
Table 7. Major Players of Other
Table 8. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 9. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Table 10. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Type (2018-2023) & ($ million)
Table 11. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2018-2023)
Table 12. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Type (2018-2023) & (USD/Kg)
Table 13. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Table 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Application (2018-2023)
Table 16. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application (2018-2023)
Table 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Application (2018-2023) & (USD/Kg)
Table 18. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Company (2018-2023) & (MT)
Table 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company (2018-2023)
Table 20. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company (2018-2023)
Table 22. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sale Price by Company (2018-2023) & (USD/Kg)
Table 23. Key Manufacturers Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Producing Area Distribution and Sales Area
Table 24. Players Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Products Offered
Table 25. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Geographic Region (2018-2023) & (MT)
Table 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Geographic Region (2018-2023)
Table 30. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country/Region (2018-2023) & (MT)
Table 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country/Region (2018-2023)
Table 34. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023) & (MT)
Table 37. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2018-2023)
Table 38. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2018-2023)
Table 40. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 41. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 42. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2018-2023) & (MT)
Table 43. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region (2018-2023)
Table 44. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Region (2018-2023)
Table 46. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 47. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 48. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023) & (MT)
Table 49. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2018-2023)
Table 50. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2018-2023)
Table 52. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 53. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 54. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Country (2018-2023) & (MT)
Table 55. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Type (2018-2023) & (MT)
Table 59. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Application (2018-2023) & (MT)
Table 60. Key Market Drivers & Growth Opportunities of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 61. Key Market Challenges & Risks of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 62. Key Industry Trends of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Table 63. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Distributors List
Table 66. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Customer List
Table 67. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2024-2029) & (MT)
Table 68. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2024-2029) & (MT)
Table 70. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Region (2024-2029) & (MT)
Table 72. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2024-2029) & (MT)
Table 74. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Country (2024-2029) & (MT)
Table 76. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Type (2024-2029) & (MT)
Table 78. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Forecast by Application (2024-2029) & (MT)
Table 80. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Akebia Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 82. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 83. Akebia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 84. Akebia Main Business
Table 85. Akebia Latest Developments
Table 86. Astellas Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 87. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 88. Astellas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 89. Astellas Main Business
Table 90. Astellas Latest Developments
Table 91. Takeda Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 92. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 93. Takeda Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 94. Takeda Main Business
Table 95. Takeda Latest Developments
Table 96. Vifor Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 97. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 98. Vifor Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 99. Vifor Main Business
Table 100. Vifor Latest Developments
Table 101. Abbvie Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 102. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 103. Abbvie Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 104. Abbvie Main Business
Table 105. Abbvie Latest Developments
Table 106. Fresenius Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 107. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 108. Fresenius Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 109. Fresenius Main Business
Table 110. Fresenius Latest Developments
Table 111. Abbott Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 112. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 113. Abbott Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 114. Abbott Main Business
Table 115. Abbott Latest Developments
Table 116. Novadiol Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 117. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 118. Novadiol Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 119. Novadiol Main Business
Table 120. Novadiol Latest Developments
Table 121. Japan Tobacco Company Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 122. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 123. Japan Tobacco Company Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 124. Japan Tobacco Company Main Business
Table 125. Japan Tobacco Company Latest Developments
Table 126. Daiichi-Sankyo Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 127. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 128. Daiichi-Sankyo Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 129. Daiichi-Sankyo Main Business
Table 130. Daiichi-Sankyo Latest Developments
Table 131. Shield Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 132. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 133. Shield Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 134. Shield Main Business
Table 135. Shield Latest Developments
Table 136. Spectrum Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 137. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 138. Spectrum Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 139. Spectrum Main Business
Table 140. Spectrum Latest Developments
Table 141. OPKO Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 142. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 143. OPKO Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 144. OPKO Main Business
Table 145. OPKO Latest Developments
Table 146. Ardelyx Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 147. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 148. Ardelyx Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 149. Ardelyx Main Business
Table 150. Ardelyx Latest Developments
Table 151. Sanofi Genzyme Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 152. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 153. Sanofi Genzyme Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 154. Sanofi Genzyme Main Business
Table 155. Sanofi Genzyme Latest Developments
Table 156. Amgen Basic Information, Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Manufacturing Base, Sales Area and Its Competitors
Table 157. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Product Portfolios and Specifications
Table 158. Amgen Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 159. Amgen Main Business
Table 160. Amgen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Control Hyperphosphatemia
Figure 10. Product Picture of Maintain Blood Calcium Levels
Figure 11. Product Picture of Control PTH Level
Figure 12. Product Picture of Correct Acidosis
Figure 13. Product Picture of Other
Figure 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2022
Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2018-2023)
Figure 16. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Hospital Pharmacies
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Hospital Pharmacies (2018-2023) & (MT)
Figure 18. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Retail Pharmacies
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Retail Pharmacies (2018-2023) & (MT)
Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Online Pharmacies
Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Online Pharmacies (2018-2023) & (MT)
Figure 22. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Drug Stores
Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Drug Stores (2018-2023) & (MT)
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Other
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Other (2018-2023) & (MT)
Figure 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2022)
Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2022
Figure 28. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market by Company in 2022 (MT)
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company in 2022
Figure 30. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company in 2022
Figure 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 35. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 36. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 37. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 38. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 39. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 41. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 42. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2022
Figure 43. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2022
Figure 44. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 45. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 46. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2022
Figure 51. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Regions in 2022
Figure 52. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 53. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 54. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2022
Figure 62. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2022
Figure 63. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 64. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 65. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 74. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2022
Figure 80. Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 81. Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 82. Channels of Distribution
Figure 83. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Forecast by Region (2024-2029)
Figure 84. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 2. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Growth Rate 2018-2029 (MT)
Figure 7. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Control Hyperphosphatemia
Figure 10. Product Picture of Maintain Blood Calcium Levels
Figure 11. Product Picture of Control PTH Level
Figure 12. Product Picture of Correct Acidosis
Figure 13. Product Picture of Other
Figure 14. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type in 2022
Figure 15. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Type (2018-2023)
Figure 16. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Hospital Pharmacies
Figure 17. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Hospital Pharmacies (2018-2023) & (MT)
Figure 18. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Retail Pharmacies
Figure 19. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Retail Pharmacies (2018-2023) & (MT)
Figure 20. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Online Pharmacies
Figure 21. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Online Pharmacies (2018-2023) & (MT)
Figure 22. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Drug Stores
Figure 23. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Drug Stores (2018-2023) & (MT)
Figure 24. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Consumed in Other
Figure 25. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Market: Other (2018-2023) & (MT)
Figure 26. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2022)
Figure 27. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Application in 2022
Figure 28. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market by Company in 2022 (MT)
Figure 29. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Company in 2022
Figure 30. Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market by Company in 2022 ($ Million)
Figure 31. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Company in 2022
Figure 32. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Geographic Region (2018-2023)
Figure 33. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Geographic Region in 2022
Figure 34. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 35. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 36. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 37. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 38. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 39. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 40. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales 2018-2023 (MT)
Figure 41. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue 2018-2023 ($ Millions)
Figure 42. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2022
Figure 43. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2022
Figure 44. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 45. Americas Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 46. United States Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 47. Canada Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 48. Mexico Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 49. Brazil Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 50. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Region in 2022
Figure 51. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Regions in 2022
Figure 52. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 53. APAC Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 54. China Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 55. Japan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 56. South Korea Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 57. Southeast Asia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 58. India Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 59. Australia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 60. China Taiwan Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 61. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2022
Figure 62. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2022
Figure 63. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 64. Europe Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 65. Germany Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 66. France Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 67. UK Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 68. Italy Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 69. Russia Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 70. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Country in 2022
Figure 71. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share by Country in 2022
Figure 72. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Type (2018-2023)
Figure 73. Middle East & Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share by Application (2018-2023)
Figure 74. Egypt Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 75. South Africa Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 76. Israel Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 77. Turkey Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 78. GCC Country Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Growth 2018-2023 ($ Millions)
Figure 79. Manufacturing Cost Structure Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) in 2022
Figure 80. Manufacturing Process Analysis of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 81. Industry Chain Structure of Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD)
Figure 82. Channels of Distribution
Figure 83. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Forecast by Region (2024-2029)
Figure 84. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Region (2024-2029)
Figure 85. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Type (2024-2029)
Figure 86. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Type (2024-2029)
Figure 87. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Sales Market Share Forecast by Application (2024-2029)
Figure 88. Global Chronic Kidney Disease–Mineral and Bone Disorders (CKD-MBD) Revenue Market Share Forecast by Application (2024-2029)
